Also trades as: DCAL.BO (BSE) · $vol 0M
DCAL.NS NSE
Dishman Carbogen Amcis Limited
1W: -10.6%
1M: -17.3%
3M: -23.5%
YTD: -28.4%
1Y: -43.8%
3Y: -1.8%
5Y: -29.3%
₹151.07 ($1.57)
+0.72 (+0.48%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$29.3B
+8.1% ▲
5Y CAGR: +8.9%
Gross Profit
$7.4B
-66.6% ▼
5Y CAGR: -12.4%
Operating Income
$2.2B
+27.4% ▲
Net Income
$974M
+2907.7% ▲
EPS (Diluted)
$6.22
+2861.9% ▲
EBITDA
$5.6B
+18.9% ▲
5Y CAGR: +14.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $21.4B | $23.2B | $26.2B | $27.1B | $29.3B |
| YoY Growth | +12.0% | +8.1% | +13.0% | +3.7% | +8.1% |
| Cost of Revenue | $4.6B | $5.3B | $7.7B | $5.0B | $21.9B |
| Gross Profit | $16.8B | $17.8B | $18.4B | $22.1B | $7.4B |
| Gross Margin | 78.6% | 76.9% | 70.5% | 81.5% | 25.2% |
| R&D Expenses | $139M | $0 | $130M | $0 | $0 |
| SG&A Expenses | $1.0B | $1.4B | $12.2B | $4.4B | $5.1B |
| Operating Expenses | $16.5B | $16.8B | $12.3B | $20.3B | $5.1B |
| Operating Income | $298M | $1.1B | -$803M | $1.8B | $2.2B |
| Operating Margin | 1.4% | 4.6% | -3.1% | 6.5% | 7.6% |
| Interest Expense | $482M | $815M | $1.1B | $1.6B | $1.7B |
| Income Before Tax | -$42M | -$546M | -$1.2B | $193M | $1.0B |
| Tax Expense | -$223M | -$248M | $312M | $161M | $74M |
| Net Income | $180M | -$298M | -$1.5B | $32M | $974M |
| Net Margin | 0.8% | -1.3% | -5.9% | 0.1% | 3.3% |
| EPS (Diluted) | $1.15 | $-1.90 | $-9.79 | $0.21 | $6.22 |
| EBITDA | $3.4B | $3.1B | $3.1B | $4.7B | $5.6B |
| Shares Outstanding | 157M | 157M | 157M | 154M | 157M |